Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Dermatologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Telogen effluvium.Clin Exp Dermatol. 2002; 27: 389-395
- The human hair cycle.J Invest Dermatol. 1959; 33: 307-316
- Chronic telogen effluvium.Dermatol Clin. 1996; 14: 723-731
- The biology of hair follicles.N Engl J Med. 1999; 341: 491-497
- Diffuse hair loss: its triggers and management.Cleve Clin J Med. 2009; 76: 361-367
- Alopecia: evaluation and treatment.Clin Cosmet Investig Dermatol. 2011; 4: 101-106
- S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents.Br J Dermatol. 2011; 164: 5-15
- Drug-associated alopecia.Int J Dermatol. 1995; 34: 149-158
- Hair loss in psychopharmacology.Ann Clin Psychiatry. 2000; 12: 35-42
- Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation.Dermatology. 2007; 215: 36-40
- Chemotherapy-induced alopecia.Semin Cutan Med Surg. 2009; 28: 11-14
- Chemotherapy-induced anagen effluvium: diffuse or patterned?.Dermatology. 2007; 215: 1-2
- Permanent alopecia after busulfan chemotherapy.Br J Dermatol. 2005; 152: 1056-1058
- Cutaneous reactions to chemotherapeutic agents.Am J Med Sci. 2001; 321: 327-335
- Classification of anticancer drugs–a new system based on therapeutic targets.Cancer Treat Rev. 2003; 29: 515-523
- Epithelium–mesenchyme compartment interaction and oncosis on chemotherapy-induced hair damage.Lab Invest. 2004; 84: 1404-1417
- A randomized trial of minoxidil in chemotherapy-induced alopecia.J Am Acad Dermatol. 1996; 35: 74-78
- Drug reactions affecting hair: diagnosis.Dermatol Clin. 2007; 25: 223-231
- Prevention of chemotherapy-induced hair loss by scalp cooling.Ann Oncol. 2005; 16: 352-358
- Hair loss in women.Minerva Ginecol. 2009; 61: 445-452
- Chronic telogen effluvium is due to a reduction in the variance of anagen duration.Australas J Dermatol. 2010; 51: 163-167
- Hair loss and lithium.Int J Dermatol. 1984; 23: 603-604
- Hair loss following lithium therapy.Br J Dermatol. 1983; 108: 503-504
- The impact of lithium in South-west Scotland. I. Demographic and clinical findings.Br J Psychiatry. 1985; 146: 70-74
- Hair loss during lithium treatment.Br J Dermatol. 1982; 107: 124-125
- Sodium valproate in treatment of epilepsy.Br Med J. 1974; 2: 584-586
- Praxis (Bern 1994). 1994; 83 ([in French]): 1132-1139
- Clinical and pharmacokinetic observations on sodium valproate—a 5-year follow-up study in 100 children with epilepsy.Acta Neurol Scand. 1982; 65: 504-523
- Effects of sodium valproate in 100 children with special reference to weight.Br Med J (Clin Res Ed). 1981; 283: 577-581
- Hair loss during fluoxetine treatment.Lancet. 1993; 342: 1423
- Hair loss associated with long-term sertraline treatment in teenager.Psychiatry (Edgmont). 2005; 2: 52
- Psychotropic medication and drug-related alopecia.Psychosomatics. 1991; 32: 149-152
- Enoxaparin-induced alopecia in patients with cerebral venous thrombosis.J Clin Pharm Ther. 2006; 31: 513-517
- Alopecia and dalteparin: a previously unreported association.Blood. 2000; 96: 1618-1619
- Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation.Blood. 2001; 97: 2914-2915
- Diffuse alopecia in a hemodialysis patient caused by a low molecular- weight heparin, tinzaparin.Am J Kidney Dis. 2003; 41: E15
- Treatment of warfarin-induced hair loss with ubidecarenone.Lancet. 1995; 346: 1104-1105
- Warfarin-induced alopecia.Cutis. 1988; 42: 63-64
- Metoprolol and alopecia.Cutis. 1981; 28: 633-634
- Propranolol and alopecia.Cutis. 1979; 24: 63-64
- Propranolol therapy.Arch Dermatol. 1977; 113: 1303
- Propranolol induced alopecia.Am Heart J. 1973; 86: 236-237
- Alopecia associated with captopril treatment.Aust N Z J Med. 1984; 14: 866
- Amiodarone and hair loss.Postgrad Med J. 1992; 68: 771
- Adverse reactions during treatment with amiodarone hydrochloride.Br Med J (Clin Res Ed). 1983; 287: 175-180
- Hair loss and contraceptives.Br Med J. 1973; 2: 499-500
- Comprehensive dermatological drug therapy. Saunders Elsevier, 2007 (p. 431)
- Repigmentation and curling of hair after acitretin therapy.Australas J Dermatol. 2009; 50: 214-216
- Isoniazid-induced alopecia.Lung India. 2011; 28: 60-61
- Alopecia side effect of antituberculosis drugs.Lancet. 1996; 347: 472
- Indinavir use: associated reversible hair loss and mood disturbance.Int J STD AIDS. 2000; 11: 474-476
- Generalized hair loss induced by indinavir plus ritonavir therapy.AIDS. 2002; 16: 1695-1696
- Product information leaflet.Bayer HealthCare Pharmaceuticals, 2009
- Onset of lichen planopilaris during treatment with etanercept.Br J Dermatol. 2008; 158: 1161-1163
- Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis.Pediatr Dermatol. 2009; 26: 118
- Childhood lichen planopilaris: a study of 87 cases.Int J Dermatol. 2001; 40: 461
- Infliximab-induced lichen planopilaris.Ann Pharmacol. 2010; 44: 1501-1503
- Tufted hair follicultis in a woman treated with trastuzumab.Target Oncol. 2010; 5: 295-296
- Skin reactions to the new biologic anticancer drugs.Curr Opin Support Palliat Care. 2009; 3: 294-299
- Nonscarring alopecia associated with the epidermal growth factor receptor inhibitor gefitinib.J Am Acad Dermatol. 2006; 55: 349-353
- Scarring Alopecia Associated with use of the epidermal growth factor receptor inhibitor gefitinib.Arch Dermatol. 2008; 144: 1524-1525
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib.J Acad Dermatol. 2011; 64: 996-998
- Folliculitis decalvans associated with erlotinib.Clin Exp Dermatol. 2010; 35: 916-918
- Tufted hair folliculitis in a woman treated with lapatinib for breast cancer.Clin Exp Dermatol. 2008; 33: 776-794
Article info
Publication history
Published online: September 20, 2012
Identification
Copyright
© 2013 Published by Elsevier Inc. All rights reserved.
